(Q48375752)

English

The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.

scientific article published on 8 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rita Ostrovskaya

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Alexander Samokhin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ludmilla Morozova-Roche

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Marina A Gruden

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Natalya A Bobkova

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Tatyana A Gudasheva

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sergey B Seredinin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Wim Noppe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Vladimir V Sherstnev

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

0 references

publication date

8 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

611-619

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092975%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

The olfactory bulbs in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Evidence-based pharmacotherapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

A nucleated assembly mechanism of Alzheimer paired helical filaments

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

How do neurons die in neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

The Morris water-escape task in mice: strain differences and effects of intra-maze contrast and brightness.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

A specific amyloid-beta protein assembly in the brain impairs memory

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Trans-neuronal regulation of cortical apoptosis in the adult rat olfactory system.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Psychiatric drug discovery and development.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Protein aggregation and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

S100B in brain damage and neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Does the human leukaemia differentiation factor fragment HLDF6 improve memory via brain DNA and protein synthesis?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Modulation of long-term memory by delayed administration of the amide of L-pyroglutamyl-D-alanine, a nootropic agent, in spaced and massed training in rats.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Prospects for antiapoptotic drug therapy of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Piracetam: a review of pharmacological properties and clinical uses.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Pathophysiological concentrations of amyloid beta proteins directly inhibit rat brain and recombinant human type II phosphatidylinositol 4-kinase activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106071335

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48375752&oldid=1450794435"